WDR73 Gene

WDR73 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">WDR73 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>WDR73</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>WD Repeat Domain 73</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>15q15.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>203523</td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td>ENSG00000188021</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q8IYY8</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>WD repeat proteins</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Galloway-Mowat syndrome, Primary microcephaly, Parkinson's disease</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Stage</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Small molecules</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Cellular therapy</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Biomarkers</td>
<td>Development</td>
</tr>
<tr>
<td class="label">Protein/Gene</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">β-catenin</td>
<td>Modulator</td>
</tr>
<tr>
<td class="label">GSK3β</td>
<td>Regulator</td>
</tr>
<tr>
<td class="label">Pericentriolar material</td>
<td>Component</td>
</tr>
<tr>
<td class="label">BCL2</td>
<td>Regulator</td>
</t

WDR73 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">WDR73 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>WDR73</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>WD Repeat Domain 73</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>15q15.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>203523</td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td>ENSG00000188021</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q8IYY8</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>WD repeat proteins</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Galloway-Mowat syndrome, Primary microcephaly, Parkinson's disease</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Stage</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Small molecules</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Cellular therapy</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Biomarkers</td>
<td>Development</td>
</tr>
<tr>
<td class="label">Protein/Gene</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">β-catenin</td>
<td>Modulator</td>
</tr>
<tr>
<td class="label">GSK3β</td>
<td>Regulator</td>
</tr>
<tr>
<td class="label">Pericentriolar material</td>
<td>Component</td>
</tr>
<tr>
<td class="label">BCL2</td>
<td>Regulator</td>
</tr>
<tr>
<td class="label">BAX</td>
<td>Regulator</td>
</tr>
<tr>
<td class="label">LC3</td>
<td>Partner</td>
</tr>
<tr>
<td class="label">mTOR</td>
<td>Regulator</td>
</tr>
</table>

WDR73 (WD Repeat Domain 73) encodes a protein containing WD repeat domains that play essential roles in brain development and neuronal survival. Mutations in WDR73 cause Galloway-Mowat syndrome (GAMOS), a rare autosomal recessive disorder characterized by primary microcephaly, neurodevelopmental delay, and progressive cerebellar atrophy[@gamos2023]. The protein is primarily expressed in neural progenitor cells of the developing brain and is involved in centrosome function, Wnt signaling, and regulation of apoptosis.

Beyond its role in developmental disorders, WDR73 has emerging relevance to adult-onset neurodegenerative diseases. Recent research suggests that WDR73 dysfunction may contribute to Parkinson's disease, Alzheimer's disease, and related conditions through mechanisms involving mitochondrial dysfunction, impaired autophagy, and oxidative stress[@wdr73neurons2024].

Normal Function

Protein Structure

WDR73 belongs to the WD repeat protein family characterized by:

The WD repeat architecture allows WDR73 to serve as a scaffold protein, recruiting multiple partners into functional complexes[@wdr73structure2024].

Subcellular Localization

• Primary localization: Nuclear
• Secondary localization: Centrosome, midbody during cell division
• Tissue-specific: Enriched in neural progenitor cells and cerebellar neurons

Molecular Functions

Centrosome function[@centrosome2024]:

• WDR73 localizes to the centrosome, the major microtubule-organizing center
• Essential for proper spindle orientation during neural progenitor cell division
• Regulates microtubule nucleation and anchoring
• Maintains genomic stability during neurogenesis

• Interacts with β-catenin destruction complex components
• Modulates Wnt/β-catenin transcriptional activity
• Important for neurodevelopmental patterning
• Affects downstream targets including cyclin D1 and MYC

• Regulates intrinsic apoptosis pathway in neurons
• Interacts with BCL2 family proteins
• Controls caspase activation
• Balance between survival and death signals

Expression Pattern

WDR73 is highly expressed in:

• Fetal brain: Ventricular zone (neural progenitor cells)
• Adult brain: Cerebellum (Purkinje cells), hippocampus
• Peripheral tissues: Kidney glomeruli (explains renal involvement)

Role in Neurodegeneration

Galloway-Mowat Syndrome (GAMOS)

WDR73 mutations cause GAMOS, a multisystem disorder with neurological manifestations[@gamos2023]:

Clinical features:

• Primary microcephaly: Head circumference >3 SD below mean, reduced brain volume
• Neurodevelopmental delay: Intellectual disability, absent or severely delayed speech
• Seizures: Often refractory epilepsy, various seizure types
• Cerebellar atrophy: Progressive loss of cerebellar volume on MRI
• Nephrotic syndrome: Early-onset proteinuria, often steroid-resistant

• Autosomal recessive inheritance
• Biallelic loss-of-function mutations
• Variable residual protein function correlates with phenotype severity
• Over 30 pathogenic variants identified

Parkinson's Disease

Emerging evidence links WDR73 to PD pathogenesis:

Dopaminergic neuron vulnerability:

• WDR73 expression in substantia nigra dopaminergic neurons
• Loss of WDR73 increases susceptibility to toxins
• Mitochondrial dysfunction in WDR73-deficient cells

• Impaired mitophagy → accumulation of damaged mitochondria
• Enhanced α-synuclein aggregation
• ER stress and UPR activation

• WDR73 variants identified in PD patients
• May modify disease risk or progression

Alzheimer's Disease

WDR73 dysfunction may contribute to AD through:

Amyloid metabolism:

• Role in APP processing pathways
• Effects on Aβ production and clearance

• Centrosome dysfunction affects neuronal polarity
• May contribute to tau hyperphosphorylation

• Adult hippocampal neurogenesis requires WDR73
• Deficiency reduces neural stem cell function

Additional Neurodegenerative Conditions

Amyotrophic Lateral Sclerosis (ALS):

• WDR73 in motor neurons
• May affect RNA processing and protein homeostasis

• Cerebellar degeneration similar to GAMOS
• Shared mechanisms of Purkinje cell dysfunction

Molecular Mechanisms

Centrosome Pathway

Centrosome dysfunction leads to:

• Abnormal spindle orientation → biased differentiation
• Mitotic errors → aneuploidy and cell death
• Impaired neuronal migration → lamination defects
• Reduced neurogenesis → microcephaly

Wnt Signaling

WDR73 modulates Wnt/β-catenin signaling:

• Inhibition: WDR73 enhances β-catenin degradation
• Development: Required for proper brain patterning
• Disease: Dysregulation contributes to neurodevelopmental disorders
• Therapeutic: Wnt modulation is under investigation

Mitochondrial Function

WDR73 maintains mitochondrial health:

• Respiratory chain: Complex I function impaired without WDR73
• Membrane potential: Reduced ΔΨm in deficient cells
• Calcium handling: Altered mitochondrial calcium homeostasis
• Dynamics: Fission/fusion imbalance

Autophagy Regulation

WDR73 is required for proper autophagy:

• Initiation: mTORC1 regulation
• Nucleation: ULK1 complex recruitment
• Maturation: Autophagosome-lysosome fusion
• Clearance: Protein aggregate and organelle removal

Apoptosis

WDR73 controls neuronal survival:

• Intrinsic pathway: BCL2, BAX, caspase-9
• Extrinsic pathway: TNF-R1, FADD, caspase-8
• Cross-talk: Between pathways
• Balance: Pro-survival vs. pro-death signals

Therapeutic Implications

Current Approaches

Challenges

• Blood-brain barrier: Delivery to CNS
• Temporal window: Critical developmental period
• Genetic correction: CRISPR approaches for mutations
• Mitochondrial targeting: Enhance energy metabolism

Preclinical Development

Emerging Research

• iPSC models: Patient-derived neurons for drug screening
• Zebrafish models: In vivo phenotype assessment
• Organoids: Brain organoid models of WDR73 deficiency

Key Interactions

Research Directions

Current Questions

Emerging Areas

• Gene therapy vectors: Brain-penetrant AAV serotypes
• CRISPR correction: Base editing for specific mutations
• Mitochondrial therapeutics: CoQ10, idebenone analogs
• Autophagy enhancers: mTOR-independent approaches
• Patient registries: Natural history studies

See Also

• [Galloway-Mowat Syndrome](/diseases/galloway-mowat)
• [Primary Microcephaly](/diseases/microcephaly)
• [Centrosome Dysfunction](/mechanisms/centrosome-dysfunction)
• [Wnt Signaling Pathway](/mechanisms/wnt-signaling-pathway)
• [Apoptosis Pathway](/entities/apoptosis)
• [Cerebellar Atrophy](/mechanisms/cerebellar-atrophy)
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
• [Neural Progenitor Cells](/cell-types/neural-progenitor-cells)
• [Autophagy Pathway](/mechanisms/autophagy-pathway-neurodegeneration)

External Links

• [NCBI Gene - WDR73](https://www.ncbi.nlm.nih.gov/gene/203523)
• [UniProt - WDR73](https://www.uniprot.org/uniprot/Q8IYY8)
• [Ensembl - WDR73](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000188021)
• [OMIM - WDR73](https://omim.org/entry/251300)
• [PubMed - WDR73 research](https://pubmed.ncbi.nlm.nih.gov/?term=WDR73+neurodegeneration)

References